Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now small index

Intracranial Neoplasm clinical trials

2 of 2 indexed Intracranial Neoplasm trials are currently recruiting.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Intracranial Neoplasm: 2 US clinical trials tracked, 2 recruiting.

Intracranial Neoplasm is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is Thomas Hope, running 1 of these trials.

Enrollment posture brief

Registry condition intracranial-neoplasm

OPEN 2 | RECR 100% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Intracranial Neoplasm (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Intracranial Neoplasm

Intracranial Neoplasm lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Intracranial Neoplasm on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Intracranial Neoplasm is recruiting above its size-band peers.

    2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Thomas Hope 1 trials
Emory University 1 trials

Named interventions

Most-linked intervention names on Intracranial Neoplasm records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Fluorethyltyrosine (18-F) Drug
1 trials
Positron Emission Tomography (PET) Procedure
1 trials
Proton Beam Radiation Therapy Radiation
1 trials
Photon Beam Radiation Therapy Radiation
1 trials
Hypofractionated Radiation Therapy Radiation
1 trials
Questionnaire Administration Other
1 trials
Quality-of-Life Assessment Other
1 trials

US sites by state

Facility locations filed on Intracranial Neoplasm trials. A trial with sites in several states counts in each.

Georgia 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Intracranial Neoplasm page

2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 Intracranial Neoplasm trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Thomas Hope sponsors the most Intracranial Neoplasm trials on record, review their full trial history before evaluating a specific study. See Thomas Hope's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Intracranial Neoplasm condition card totals 2 registered trials; most-linked intervention Fluorethyltyrosine (18-F); top US site state Georgia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.